Tapewire

Nasdaq · USD

PCVX

Vaxcyte, Inc.

Export transactions ↓
Tapewire entity
1164
SEC CIK
0001649094
Parsed reports
418

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202600
Feb 202600
Mar 202605
Apr 202603
May 202601
Jun 2026016
Jul 2026011
Aug 202605
Sep 202606
Oct 202604

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 07, 2024 Filed Jun 10, 2024 20:13 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
Tax withholdingCommon Stock 335 $70.97 $23,774.95
Disclosure

SEC source: 0001649094-24-000016 · wk-form4_1718050409.xml · nonDerivative · entry 1

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,826

F1 · shares: Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:07 UTC
Hirth PeterDirector
GrantStock Option (right to buy) · Derivative 7,250 $0.00 Strike: $72.51 $0.00
Disclosure

SEC source: 0001649094-24-000010 · wk-form4_1718050014.xml · derivative · entry 3

Hirth Peter · CIK 0001813780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,250

Underlying: Common Stock · 7,250 shares

Expires 2034-06-05

F2 · derivative.exercise_date: The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:07 UTC
Hirth PeterDirector
GrantCommon Stock 1,550 $0.00 $0.00
Disclosure

SEC source: 0001649094-24-000010 · wk-form4_1718050014.xml · nonDerivative · entry 1

Hirth Peter · CIK 0001813780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,175

F1 · shares: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:09 UTC GrantStock Option (right to buy) · Derivative 7,250 $0.00 Strike: $72.51 $0.00
Disclosure

SEC source: 0001649094-24-000012 · wk-form4_1718050182.xml · derivative · entry 2

Lukatch Heath · CIK 0001596385 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,250

Underlying: Common Stock · 7,250 shares

Expires 2034-06-05

F2 · derivative.exercise_date: The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:09 UTC GrantCommon Stock 1,550 $0.00 $0.00
Disclosure

SEC source: 0001649094-24-000012 · wk-form4_1718050182.xml · nonDerivative · entry 1

Lukatch Heath · CIK 0001596385 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,175

F1 · shares: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:11 UTC
Loxam TeriDirector
GrantStock Option (right to buy) · Derivative 7,250 $0.00 Strike: $72.51 $0.00
Disclosure

SEC source: 0001649094-24-000014 · wk-form4_1718050286.xml · derivative · entry 2

Loxam Teri · CIK 0001829111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,250

Underlying: Common Stock · 7,250 shares

Expires 2034-06-05

F2 · derivative.exercise_date: The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:11 UTC
Loxam TeriDirector
GrantCommon Stock 1,550 $0.00 $0.00
Disclosure

SEC source: 0001649094-24-000014 · wk-form4_1718050286.xml · nonDerivative · entry 1

Loxam Teri · CIK 0001829111 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,175

F1 · shares: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:12 UTC
Lee JacksDirector
GrantStock Option (right to buy) · Derivative 7,250 $0.00 Strike: $72.51 $0.00
Disclosure

SEC source: 0001649094-24-000015 · wk-form4_1718050330.xml · derivative · entry 2

Lee Jacks · CIK 0001935943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,250

Underlying: Common Stock · 7,250 shares

Expires 2034-06-05

F2 · derivative.exercise_date: The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:12 UTC
Lee JacksDirector
GrantCommon Stock 1,550 $0.00 $0.00
Disclosure

SEC source: 0001649094-24-000015 · wk-form4_1718050330.xml · nonDerivative · entry 1

Lee Jacks · CIK 0001935943 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,550

F1 · shares: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:10 UTC GrantStock Option (right to buy) · Derivative 7,250 $0.00 Strike: $72.51 $0.00
Disclosure

SEC source: 0001649094-24-000013 · wk-form4_1718050236.xml · derivative · entry 2

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,250

Underlying: Common Stock · 7,250 shares

Expires 2034-06-05

F2 · derivative.exercise_date: The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:10 UTC GrantCommon Stock 1,550 $0.00 $0.00
Disclosure

SEC source: 0001649094-24-000013 · wk-form4_1718050236.xml · nonDerivative · entry 1

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,175

F1 · shares: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:08 UTC GrantStock Option (right to buy) · Derivative 7,250 $0.00 Strike: $72.51 $0.00
Disclosure

SEC source: 0001649094-24-000011 · wk-form4_1718050106.xml · derivative · entry 2

Drapeau Anne S · CIK 0001296569 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,250

Underlying: Common Stock · 7,250 shares

Expires 2034-06-05

F2 · derivative.exercise_date: The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:08 UTC GrantCommon Stock 1,550 $0.00 $0.00
Disclosure

SEC source: 0001649094-24-000011 · wk-form4_1718050106.xml · nonDerivative · entry 1

Drapeau Anne S · CIK 0001296569 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,175

F1 · shares: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:05 UTC GrantStock Option (right to buy) · Derivative 7,250 $0.00 Strike: $72.51 $0.00
Disclosure

SEC source: 0001649094-24-000009 · wk-form4_1718049932.xml · derivative · entry 3

Paya Carlos V · CIK 0001606244 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,250

Underlying: Common Stock · 7,250 shares

Expires 2034-06-05

F3 · derivative.exercise_date: The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 06, 2024 Filed Jun 10, 2024 20:05 UTC GrantCommon Stock 1,550 $0.00 $0.00
Disclosure

SEC source: 0001649094-24-000009 · wk-form4_1718049932.xml · nonDerivative · entry 1

Paya Carlos V · CIK 0001606244 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,050

F1 · shares: Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:57 UTC
Wassil JimCHIEF OPERATING OFFICER
SaleCommon Stock 460 $73.48 $33,798.50
Disclosure

SEC source: 0001415889-24-015587 · form4-06052024_080638.xml · nonDerivative · entry 3

Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,503

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023.

F5 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $73.41 to $73.54. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:57 UTC
Wassil JimCHIEF OPERATING OFFICER
SaleCommon Stock 906 $72.32 $65,521.01
Disclosure

SEC source: 0001415889-24-015587 · form4-06052024_080638.xml · nonDerivative · entry 2

Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,964

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023.

F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $72.01 to $72.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:57 UTC
Wassil JimCHIEF OPERATING OFFICER
SaleCommon Stock 1,634 $71.38 $116,641.46
Disclosure

SEC source: 0001415889-24-015587 · form4-06052024_080638.xml · nonDerivative · entry 1

Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 214,869

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $70.98 to $71.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 1,041 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:59 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 18,200 $0.00 Strike: $5.35 $0.00
Disclosure

SEC source: 0001415889-24-015590 · form4-06052024_080637.xml · derivative · entry 3

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,374

Underlying: Common Stock · 18,200 shares

Expires 2030-04-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option is fully vested and exercisable.

F3 · balance_after: Reporting Person has transferred 30,374 vested stock options to Reporting Person's ex-spouse pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Accordingly, Reporting Person will not report beneficial ownership of or dispositions or acquisitions of the underlying shares in future Section 16(a) filings.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:59 UTC SaleCommon Stock 18,200 $73.00 $1,328,600.00
Disclosure

SEC source: 0001415889-24-015590 · form4-06052024_080637.xml · nonDerivative · entry 2

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,625

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:59 UTC Exercise / conversionCommon Stock 18,200 $5.35 $97,370.00
Disclosure

SEC source: 0001415889-24-015590 · form4-06052024_080637.xml · nonDerivative · entry 1

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,825

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:58 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
Exercise / conversionStock Option (right to buy) · Derivative 1,667 $0.00 Strike: $21.41 $0.00
Disclosure

SEC source: 0001415889-24-015589 · form4-06052024_080641.xml · derivative · entry 5

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,998

Underlying: Common Stock · 1,667 shares

Expires 2032-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: 1/4 of the shares subject to the option vested on April 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:58 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
SaleCommon Stock 260 $73.64 $19,145.62
Disclosure

SEC source: 0001415889-24-015589 · form4-06052024_080641.xml · nonDerivative · entry 4

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,161

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023.

F5 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $73.46 to $73.82. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:58 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
SaleCommon Stock 656 $72.37 $47,472.10
Disclosure

SEC source: 0001415889-24-015589 · form4-06052024_080641.xml · nonDerivative · entry 3

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,421

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023.

F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $72.08 to $72.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:58 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
SaleCommon Stock 751 $71.25 $53,509.50
Disclosure

SEC source: 0001415889-24-015589 · form4-06052024_080641.xml · nonDerivative · entry 2

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,077

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $70.98 to $71.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:58 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
Exercise / conversionCommon Stock 1,667 $21.41 $35,690.47
Disclosure

SEC source: 0001415889-24-015589 · form4-06052024_080641.xml · nonDerivative · entry 1

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 564 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2024.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:56 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 224 $73.43 $16,449.22
Disclosure

SEC source: 0001415889-24-015586 · form4-06052024_080635.xml · nonDerivative · entry 6

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Children's Trust

Disclosed balance after: 144,746

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F7 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $73.41 to $73.46. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's son.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:56 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 327 $72.55 $23,723.20
Disclosure

SEC source: 0001415889-24-015586 · form4-06052024_080635.xml · nonDerivative · entry 5

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Children's Trust

Disclosed balance after: 144,970

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F6 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $72.13 to $72.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's son.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:56 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 757 $71.43 $54,071.00
Disclosure

SEC source: 0001415889-24-015586 · form4-06052024_080635.xml · nonDerivative · entry 4

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Children's Trust

Disclosed balance after: 145,297

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $70.98 to $71.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's son.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:56 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 117 $73.46 $8,594.82
Disclosure

SEC source: 0001415889-24-015586 · form4-06052024_080635.xml · nonDerivative · entry 3

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Children's Trust

Disclosed balance after: 144,746

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F3 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:56 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 486 $72.66 $35,311.30
Disclosure

SEC source: 0001415889-24-015586 · form4-06052024_080635.xml · nonDerivative · entry 2

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Children's Trust

Disclosed balance after: 144,863

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $72.155 to $73.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:56 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 705 $71.44 $50,362.38
Disclosure

SEC source: 0001415889-24-015586 · form4-06052024_080635.xml · nonDerivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Children's Trust

Disclosed balance after: 145,349

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $70.98 to $71.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

Read SEC document
May 23, 2024 Filed May 28, 2024 20:22 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001415889-24-014661 · form4-05282024_080505.xml · derivative · entry 6

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 212,327

Underlying: Common Stock · 15,000 shares

Expires 2028-07-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Stock Option is fully vested and exercisable.

Read SEC document
May 23, 2024 Filed May 28, 2024 20:22 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 8,789 $69.84 $613,823.76
Disclosure

SEC source: 0001415889-24-014661 · form4-05282024_080505.xml · nonDerivative · entry 3

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 477,847

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $69.56 to $71.34. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 23, 2024 Filed May 28, 2024 20:22 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 6,211 $68.84 $427,583.87
Disclosure

SEC source: 0001415889-24-014661 · form4-05282024_080505.xml · nonDerivative · entry 2

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 486,636

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $68.32 to $69.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 23, 2024 Filed May 28, 2024 20:22 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionCommon Stock 15,000 $2.03 $30,450.00
Disclosure

SEC source: 0001415889-24-014661 · form4-05282024_080505.xml · nonDerivative · entry 1

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 492,847

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 20, 2024 Filed May 22, 2024 21:03 UTC
GUGGENHIME ANDREWPRESIDENT AND CFO
Exercise / conversionStock Option (right to buy) · Derivative 8,000 $0.00 Strike: $5.35 $0.00
Disclosure

SEC source: 0001415889-24-014108 · form4-05222024_090512.xml · derivative · entry 4

GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 352,827

Underlying: Common Stock · 8,000 shares

Expires 2030-05-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter.

Read SEC document
May 20, 2024 Filed May 22, 2024 21:03 UTC
GUGGENHIME ANDREWPRESIDENT AND CFO
SaleCommon Stock 4,456 $75.46 $336,249.76
Disclosure

SEC source: 0001415889-24-014108 · form4-05222024_090512.xml · nonDerivative · entry 3

GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 95,679

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $74.95 to $75.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 20, 2024 Filed May 22, 2024 21:03 UTC
GUGGENHIME ANDREWPRESIDENT AND CFO
SaleCommon Stock 3,544 $74.40 $263,659.42
Disclosure

SEC source: 0001415889-24-014108 · form4-05222024_090512.xml · nonDerivative · entry 2

GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,135

F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted June 30, 2023.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $73.95 to $74.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 20, 2024 Filed May 22, 2024 21:03 UTC
GUGGENHIME ANDREWPRESIDENT AND CFO
Exercise / conversionCommon Stock 8,000 $5.35 $42,800.00
Disclosure

SEC source: 0001415889-24-014108 · form4-05222024_090512.xml · nonDerivative · entry 1

GUGGENHIME ANDREW · CIK 0001230724 · PRESIDENT AND CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:19 UTC
Wassil JimCHIEF OPERATING OFFICER
SaleCommon Stock 185 $63.65 $11,774.51
Disclosure

SEC source: 0001415889-24-012166 · form4-05032024_080545.xml · nonDerivative · entry 3

Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 215,462

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023.

F5 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $63.37 to $63.905. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:19 UTC
Wassil JimCHIEF OPERATING OFFICER
SaleCommon Stock 1,062 $61.99 $65,836.57
Disclosure

SEC source: 0001415889-24-012166 · form4-05032024_080545.xml · nonDerivative · entry 2

Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 215,647

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023.

F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $61.775 to $62.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:19 UTC
Wassil JimCHIEF OPERATING OFFICER
SaleCommon Stock 1,753 $61.23 $107,330.93
Disclosure

SEC source: 0001415889-24-012166 · form4-05032024_080545.xml · nonDerivative · entry 1

Wassil Jim · CIK 0001813798 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 216,709

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2023.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $60.76 to $61.495. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · balance_after: The Reporting Person has entered into a divorce settlement agreement with his ex-spouse (the "Settlement Agreement") pursuant to a "domestic relations order" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. Since the date of the Reporting Person's ownership report filed on April 19, 2024, the Reporting Person transferred 3,378 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:20 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
Exercise / conversionStock Option (right to buy) · Derivative 1,667 $0.00 Strike: $21.41 $0.00
Disclosure

SEC source: 0001415889-24-012169 · form4-05032024_080526.xml · derivative · entry 5

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 186,665

Underlying: Common Stock · 1,667 shares

Expires 2032-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: 1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:20 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
SaleCommon Stock 144 $63.90 $9,202.03
Disclosure

SEC source: 0001415889-24-012169 · form4-05032024_080526.xml · nonDerivative · entry 4

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,597

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023.

F4 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $63.87 to $63.905. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:20 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
SaleCommon Stock 559 $61.95 $34,628.93
Disclosure

SEC source: 0001415889-24-012169 · form4-05032024_080526.xml · nonDerivative · entry 3

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,741

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023.

F3 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $61.755 to $62.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:20 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
SaleCommon Stock 964 $61.30 $59,090.31
Disclosure

SEC source: 0001415889-24-012169 · form4-05032024_080526.xml · nonDerivative · entry 2

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,300

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 29, 2023.

F2 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $60.76 to $61.69. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:20 UTC
Eydelman MikhailSVP, GEN COUNSEL & CORP SEC
Exercise / conversionCommon Stock 1,667 $21.41 $35,690.47
Disclosure

SEC source: 0001415889-24-012169 · form4-05032024_080526.xml · nonDerivative · entry 1

Eydelman Mikhail · CIK 0001918033 · SVP, GEN COUNSEL & CORP SEC

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,264

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:18 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 46 $63.84 $2,936.64
Disclosure

SEC source: 0001415889-24-012165 · form4-05032024_080551.xml · nonDerivative · entry 6

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Children's Trust

Disclosed balance after: 146,054

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F6 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's son.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:18 UTC
PICKERING GRANTDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 582 $62.07 $36,122.41
Disclosure

SEC source: 0001415889-24-012165 · form4-05032024_080551.xml · nonDerivative · entry 5

PICKERING GRANT · CIK 0001258693 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Indirect · By Children's Trust

Disclosed balance after: 146,100

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F7 · price: The price reported is a weighted-average price. The shares were sold at prices ranging from $61.755 to $62.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F6 · ownership.nature: Shares are held directly by a trust for the benefit of the Reporting Person's son.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.